Senior insider sale
President & CEO at LYRA THERAPEUTICS, INC. — senior position signals high conviction
$9.6K
2.24K shares
What this filing means
PALASIS MARIA plans to sell 2.24K shares of LYRA THERAPEUTICS, INC. valued at approximately $9.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/6/2026ACC: 0001959173-26-000158
DirectorOfficer· President & CEO
Since Apr 2020
2.24K
Shares to sell
$9.6K
Approx. market value
1.70K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
1/2/2026
1.70KTotal acquired1.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2026 | Restricted Stock Vesting Compensation | 1.70K | — |
| Total | 1.70K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
537.00
Market value
$3.9K
10/14/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.70K
Market value
$5.7K
1/6/2026
Total
Units
2.24K
Value
$9.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/14/2025 | 537.00 | $3.9K | — | Completed |
| Planned — Approximate Date | ||||
1/6/2026 | 1.70K | $5.7K | NASDAQ | Planned |
| Total | 2.24K | $9.6K | ||